BRIEF—Toho Holidings aquires share of Tokyo-based startup

Privately-held drugs wholesaler Toho Holdings has bought a 6% equity stake in fellow Tokyo-based firm HekaBio under a third-party share allotment scheme.

The biotech startup, which was founded in late 2016, says it is focused on developing innovative therapeutics in oncology and for autoimmune/inflammatory diseases.